These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34836984)

  • 1. The herd-immunity threshold must be updated for multi-vaccine strategies and multiple variants.
    Yadegari I; Omidi M; Smith SR
    Sci Rep; 2021 Nov; 11(1):22970. PubMed ID: 34836984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
    Gumel AB; Iboi EA; Ngonghala CN; Ngwa GA
    Front Public Health; 2021; 9():709369. PubMed ID: 34368071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network models to evaluate vaccine strategies towards herd immunity in COVID-19.
    Tetteh JNA; Nguyen VK; Hernandez-Vargas EA
    J Theor Biol; 2021 Dec; 531():110894. PubMed ID: 34508758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia.
    MacIntyre CR; Costantino V; Trent M
    Vaccine; 2022 Apr; 40(17):2506-2513. PubMed ID: 33958223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical assessment of the impact of vaccine-type and immunity on the burden of COVID-19.
    Taboe HB; Asare-Baah M; Iboi EA; Ngonghala CN
    Math Biosci; 2023 Jun; 360():108981. PubMed ID: 36803672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R
    Elsaid M; Nasef MA; Huy NT
    Hum Vaccin Immunother; 2021 Nov; 17(11):3850-3854. PubMed ID: 34612165
    [No Abstract]   [Full Text] [Related]  

  • 8. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herd immunity: challenges and the way forward in Korea.
    Oh J; Kim S; Ryu B; Shin M; Kim BI
    Epidemiol Health; 2021; 43():e2021054. PubMed ID: 34412446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants.
    Liu F; Zhao Z; Ma C; Nie X; Wu A; Li X
    Epidemiol Infect; 2022 Jan; 150():e46. PubMed ID: 35067231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Africa achieve herd immunity?
    Lucero-Prisno DE; Ogunkola IO; Esu EB; Adebisi YA; Lin X; Li H
    Glob Health Res Policy; 2021 Dec; 6(1):46. PubMed ID: 34852844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Great Expectations of COVID-19 Herd Immunity.
    Giurgea LT; Morens DM
    mBio; 2022 Feb; 13(1):e0349521. PubMed ID: 35073740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.
    Daher-Nashif S; Al-Anany R; Ali M; Erradi K; Farag E; Abdallah AM; Emara MM
    Arch Virol; 2022 Sep; 167(9):1773-1783. PubMed ID: 35723757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant.
    Hodgson D; Flasche S; Jit M; Kucharski AJ; ;
    Euro Surveill; 2021 May; 26(20):. PubMed ID: 34018481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A country-specific model of COVID-19 vaccination coverage needed for herd immunity in adult only or population wide vaccination programme.
    Goh FT; Chew YZ; Tam CC; Yung CF; Clapham H
    Epidemics; 2022 Jun; 39():100581. PubMed ID: 35636311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
    Kwok KO; McNeil EB; Tsoi MTF; Wei VWI; Wong SYS; Tang JWT
    J Infect; 2021 Sep; 83(3):381-412. PubMed ID: 34118274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herd Immunity to Ebolaviruses Is Not a Realistic Target for Current Vaccination Strategies.
    Masterson SG; Lobel L; Carroll MW; Wass MN; Michaelis M
    Front Immunol; 2018; 9():1025. PubMed ID: 29867992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations make pandemics worse or better: modeling SARS-CoV-2 variants and imperfect vaccination.
    Bugalia S; Tripathi JP; Wang H
    J Math Biol; 2024 Mar; 88(4):45. PubMed ID: 38507066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.
    Shelly A; Gupta P; Ahuja R; Srichandan S; Meena J; Majumdar T
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33050511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To give or not to give? Pandemic vaccine donation policy.
    Holleran A; Martonosi SE; Veatch M
    Public Health; 2024 Aug; 233():164-169. PubMed ID: 38897068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.